1. MARKETS
  2. SECTOR : HARDWARE TECHNOLOGY & EQUIPMENT
  3. INDUSTRY : SEMICONDUCTORS
  4. SMARTKEM INC
SmartKem Inc
XNAS: SMTK
Download real time
0.64 0.04 (6.67%)
New 52W Low in past week
218.7K
XNAS Volume
High vol.+loss this week

XNAS 15 Oct, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for SmartKem Inc

The latest disclosure was made by Dr. Steven P. DenBaars, PhD in SmartKem Inc where a trade of 22,466 Stock Option (right to buy) done was reported to US exchanges on Sept. 3, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Dr. Steven P. DenBaars, PhD Director 03 Sep 2025 22,466 22,466 - - Stock Option (right to buy)
Ms. Melisa A. Denis Director 03 Sep 2025 22,466 22,466 - - Stock Option (right to buy)
Mr. Ian Tudor Jenks Director, Chairman & CEO 03 Sep 2025 160,005 160,005 - - Stock Option (right to buy)
Mr. Klaas de Boer Director 03 Sep 2025 22,466 22,466 - - Stock Option (right to buy)
Mr. Sriram Peruvemba Director 03 Sep 2025 22,466 22,466 - - Stock Option (right to buy)
Ms. Barbra C. Keck Chief Financial Officer 03 Sep 2025 71,077 71,077 - - Stock Option (right to buy)
Mr. Klaas de Boer Director 28 May 2025 23,915 23,915 - - Stock Option (right to Buy)
Mr. Jonathan Watkins Chief Operating Officer 28 May 2025 131,745 131,745 - - Stock Option (right to Buy)
Dr. Simon Ogier, PhD Chief Technology Officer 28 May 2025 77,656 77,656 - - Stock Option (right to Buy)
Dr. Beverley Brown, PhD Chief Scientist 28 May 2025 33,741 33,741 - - Stock Option (right to Buy)
Ms. Melisa A. Denis Director 28 May 2025 23,915 23,915 - - Stock Option (right to Buy)
Dr. Steven P. DenBaars, PhD Director 28 May 2025 23,915 23,915 - - Stock Option (right to Buy)
Mr. Ian Tudor Jenks Director, Chairman & CEO 28 May 2025 170,320 170,320 - - Stock Option (right to Buy)
Mr. Sriram Peruvemba Director 28 May 2025 23,915 23,915 - - Stock Option (right to Buy)
Ms. Barbra C. Keck Chief Financial Officer 28 May 2025 75,660 75,660 - - Stock Option (right to Buy)
Dr. Simon Ogier, PhD Chief Technology Officer 14 Jun 2024 49,000 49,000 - - Employee stock option (Right to Buy)
Dr. Beverley Brown, PhD Chief Scientist 14 Jun 2024 49,000 49,000 - - Employee stock option (Right to Buy)
Ms. Melisa A. Denis Director 14 Jun 2024 20,000 20,000 - - Employee stock option (Right to Buy)
Dr. Steven P. DenBaars, PhD Director 14 Jun 2024 20,000 20,000 - - Employee stock option (Right to Buy)
Mr. Ian Tudor Jenks Director, Chairman & CEO 14 Jun 2024 16,000 16,000 - - Employee stock option (Right to Buy)
Mr. Ian Tudor Jenks Director, Chairman & CEO 14 Jun 2024 165,000 165,000 - - Employee stock option (Right to Buy)
Mr. Klaas de Boer Director 14 Jun 2024 20,000 20,000 - - Employee stock option (Right to Buy)
Mr. Sriram Peruvemba Director 14 Jun 2024 20,000 20,000 - - Employee stock option (Right to Buy)
Ms. Barbra C. Keck Chief Financial Officer 14 Jun 2024 100,000 100,000 - - Employee stock option (Right to Buy)
Mr. Klaas de Boer Director 30 May 2024 5,715 11,430 - - Common Stock
Mr. Klaas de Boer Director 30 May 2024 50 0 - - Series A-2 Convertible Preferred Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters